• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Will Cannabis Genetics Be Banned?

A redefinition of hemp under federal law, scheduled to take effect Nov. 12, spells the loss of Farm Bill protections for many hemp-derived THC products across the country: mild beverages as well as THCA bud and delta-8 THC edibles, vapes and other products available at gas stops and smoke shops.

But the hemp prohibition also creates a significant complication for the legal cannabis sector. Seeds from cannabis cultivars that generate flower with greater than 0.3% THC are no longer legal to transport out of state.

Although seed purchases will likely continue in legal states, the changes threaten to shutter some seed banks and genetics companies, observers note, while creating supply-chain issues for cannabis growers and retailers.

"If this wording goes through, we will require pop-up shops to sell seeds in every state where it's permitted," Campanella said. "Which is why we're also providing clones and tissue cultivation, because that's not covered in the bill."

When are cannabis genetics and clones illegal to ship between state lines?

The new regulations categorize seeds based on the THC potential of the mother plant. Genetic material such as seeds and clones are rendered illegal if the end product crosses the threshold.

For now, seeds are currently shipping under the 2018 Farm Bill's current quo. But the time is ticking for businesses like Brothers Grimm and for cannabis growers who fear supply chain disruptions if out-of-state availability to genetics is banned.

Most of the cannabis sector remains largely unaware of the impending shutdown of the interstate genetics marketplace, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.

Without government intervention in the way of a carve-out for seeds or a general moratorium, many seed providers will simply be shuttered by November, he added.

"We are operating legally currently, but if that shifts, it will upend the legal licensed sector in every state," said Power, whose clientele includes seed banks as well as licensed business cultivators.

"Customers are going to forfeit choice, and it will be a significant shutdown for most people."

What are cannabis seed suppliers doing to remain legal after the federal hemp ban?

Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis supervision in that state while also restricting hemp-derived THC items to licensed cannabis retailers.

Previously a seed supplier, Silberhaze is currently focused on the branding, preservation and IP safeguarding of elite plant genetics.

That's because seed companies hoping to remain compliant in this new environment must have airtight documentation, he said.

"You have to demonstrate where this stuff comes from, so it's extremely important to have documentation, even to the extent where you have cultivator names," Silber said.

"Smaller businesses will have to operate with improved records and a stronger chain of possession," he added. "We need that documentation too, because we don't want to be dealing with shady sources."

To prevent seizures and additional legal fallout, seed business owners must "get their affairs in order" before the updated regulations take effect, Silber said.

"Audit all your stuff immediately, and categorize what you can," Silber said. "Take stock, document your lineage, preserve breeder records, and arrange any cannabinoid or terpene data you currently have. If regulations change, you'll be in a far better position to comprehend what may be impacted and make informed decisions."

Does federal marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration registration may be necessary for companies engaged in research.

But for the time being, seed companies can't register with the DEA like state-licensed therapeutic cannabis operators can. Such a pathway is unavailable to seed banks, nurseries or genetics companies, said Jim Ickes, an attorney and partner with Frantz Ward's cannabis law group in Cleveland.

"Genetics activity may be happening inside broader state-licensed therapeutic marijuana operations, as some states allow dispensaries or registered medical operators to sell seeds, clones or personal growing materials," he said.

"But that is different from the DEA creating a freestanding seed bank registration category."

Some genetics companies are already changing operational practices to conform with the updated law. According to Ickes, they must answer questions including:

• Which of our varieties produce plants over 0.3% total THC?
• Which seeds survive as hemp after Nov. 12, 2026, and which don't?
• What does our catalog look like once we organize it against the viable-seed exclusion?

Ickes also recognizes confusion from customers who believed government rescheduling of therapeutic marijuana would clarify their situation with banking institutions. However, the latest regulatory wording has moved those conversations beyond the basics of classification, https://nativesusa.com/) he said.

"Banks ask whether this specific revenue stream is lawful, whether it ties to state-licensed operations, or whether there's cross-state risk," said Ickes.

"After November, a seed supplier selling drug-type genetics can't address the initial question with the hemp classification. It has to refer to a legal state cannabis pathway instead. Seed banks dealing in authentic industrial-hemp seed keep the cleaner story."

What's the future of cannabis genetics?

Campanella is part of a emerging coalition of other breeders, growers and researchers that's arguing seeds are better defined as agricultural inputs than controlled substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, leaving the DEA to concentrate its enforcement efforts elsewhere.

"How do you regulate something based on what it could become later?" said Campanella. "Our choice is to have that wording removed, or have seeds regulated by the USDA as a hemp product."

But in the interim, Campanella is reorganizing Brothers Grimm to function outside the reach of shifting federal oversight. The company plans to maintain its Colorado seed facility while positioning its Oklahoma tissue culture facility as a hedge against federal prohibition of cannabis seeds.

As she explained: "If things develop in a way where we can't focus on interstate shipping, we'll have additional resources to satisfy people's requirements without getting ourselves in trouble."